Gene · 3980
NIH grants1,564
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,564
Download this page as JSON| Grant | Title | LIG3 papers | Newest fiscal year |
|---|---|---|---|
| R01AA028859 | Redox Regulation of O-GlcNAcylation Signaling in the Pathogenesis of Alcoholic Fatty Liver Disease | 1 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 1 | 2025 |
| R01AG071869 | Defining the programmed proteome rejuvenation underlying gametogenesis | 1 | 2025 |
| R01AG076448 | TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease | 1 | 2025 |
| R01AI020047 | Mechanisms That Control Antigen Receptor Variable Region Exon Assembly | 1 | 2025 |
| R01AI107301 | Genetic Viral and Host Adaptations to Breach Species Barriers of HCV | 1 | 2025 |
| R01AI134818 | The Role of HBeAg in HBV Persistence | 1 | 2025 |
| R01AI158361 | ROLES OF HOST FACTORS IN VIRAL REPLICATION COUPLED PROCESSES | 1 | 2025 |
| R01AI161363 | Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2 | 1 | 2025 |
| R01CA067985 | DNA Damage Repair by MUTYH and MUTYH Variants Associated with Colorectal Cancer | 1 | 2025 |
| R01CA073764 | FEN1-mediated Okazaki fragment maturation and its deficiency in cancer | 1 | 2025 |
| R01CA074305 | Chemical Approaches to Cell Signaling Enzymes | 1 | 2025 |
| R01CA136367 | Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus | 1 | 2025 |
| R01CA140657 | Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2 | 1 | 2025 |
| R01CA142861 | Renewal: HPV and the DNA Damage Response | 1 | 2025 |
| R01CA168635 | Mechanistic Dissection of the BRCA1-SETX-dependent Pathway of R-loop Avoidance and Genome Maintenance | 1 | 2025 |
| R01CA174904 | Roles of Chromatin Modification in BRCA1 Dependent DNA Repair | 1 | 2025 |
| R01CA193343 | Leveraging genetic mapping for personalized targeting of breast cancer microenvironment | 1 | 2025 |
| R01CA197774 | Regulation of DNA synthesis in response to DNA damage | 1 | 2025 |
| R01CA201246 | Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/grants?page=8